{"SPADE_N_06265": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06265", "Peptide Name": "EGFR-related peptide", "Source": "EGFR-related peptide", "Family": "", "Gene": "Not found", "Sequence": "ERRP", "Sequence Length": 4, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PC-3 (30% Cell viability at 5 Âµg/ml)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C22H40N10O7", "Mass": 556.62, "PI": 9.7, "Net Charge": 1, "Hydrophobicity": -3.52, "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour", "Comments": "ERRP inhibits the growth of prostate cancer cells by attenuating EGFR signaling processes", "Literature": [{"Title": "Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells", "Pubmed ID": "15634655", "Reference": "Mol Cancer Ther. 2004 Dec;3(12)1615-21.", "Author": "Marciniak DJ, Rishi AK, Sarkar FH, Majumdar AP.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15634655"}], "Frequent Amino Acids": "REP", "Absent Amino Acids": "ACDFGHIKLMNOQSTUVWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 1, "Polar Residues": 2, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00631", "Similarity": 1.0, "Sequence": "EESRMNINAERRPWCPSKIQMFDTNCEVDGAKQCLDLLISTWDPSVRLTRVSCICSDFPYRNMMCSCPNMICP"}, {"SPADE_ID": "SPADE_N_04462", "Similarity": 1.0, "Sequence": "EERRPGSVDVPLPESNIVRTIMEFLSFLHLKEAGALDSLPGIPLATSSEDLEKS"}, {"SPADE_ID": "SPADE_N_09557", "Similarity": 1.0, "Sequence": "ILPEKEPEEPERR"}]}}}